CAIMH
PFE icon

Central Asset Investments & Management Holdings’s Pfizer PFE Stock Holding History

Central Asset Investments & Management Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,888
Closed -$518K – 40
2022
Q2 		$518K Sell
9,888
-48,798
-83% -$2.49M 1.02% 19
2022
Q1 		$3.04M Sell
58,686
-28,400
-33% -$1.47M 1.99% 9
2021
Q4 		$5.14M Buy
87,086
+76,086
+692% +$3.77M 3.13% 10
2021
Q3 		$473K Buy
+11,000
New +$487K 0.25% 51

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Central Asset Investments & Management Holdings's PFE Position: Q3 2022 in Review

Central Asset Investments & Management Holdings sold out of Pfizer (PFE) in Q3 2022, closing a stake of 9,888 shares — an estimated $518K sold.

Central Asset Investments & Management Holdings first reported a position in PFE in Q3 2021 and held it in 4 quarters. The position peaked at $5.14M in Q4 2021. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Central Asset Investments & Management Holdings reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • Central Asset Investments & Management Holdings sold 9,888 Pfizer shares in Q3 2022, an estimated $518K.
  • Central Asset Investments & Management Holdings first reported a position in Pfizer in Q3 2021 and held it in 4 quarters.
  • Central Asset Investments & Management Holdings's Pfizer position peaked at $5.14M in Q4 2021.
  • 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Central Asset Investments & Management Holdings's 13F filing for Q3 2022, filed 4 Nov 2022.